Search

Your search keyword '"Rudenko, Michael"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Rudenko, Michael" Remove constraint Author: "Rudenko, Michael"
143 results on '"Rudenko, Michael"'

Search Results

1. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

2. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice

3. Deviation of the Nasal Septum

4. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study

6. Influenza in Children

7. Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.

8. Usage prevalence of angioedema patient-reported outcome measures: results from the UCARE and ACARE PROMUSE study

12. Enhancing Angioedema Patient Care: Unveiling Underutilization and Barriers in the Implementation of Patient-Reported Outcome Measurements

13. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

14. How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19

16. Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

18. Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: results of PREG-CU, a UCARE study

19. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination:Results of the UCARE COVAC-CU study

21. Total IgE levels are linked to the course of chronic spontaneous urticaria during pregnancy

22. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

23. Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU , a UCARE study

25. Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries

26. Risk factors for systemic reactions in typical cold urticaria:Results from the COLD-CE study

27. Adrenaline autoinjector is underprescribed in typical cold urticaria patients

28. Adrenaline autoinjector is underprescribed in typical cold urticaria patients

29. Risk factors for systemic reactions in typical cold urticaria: Results from the COLD‐CE study

30. Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU, a UCARE study.

31. Low and high IgE is linked to improvement and worsening of chronic urticaria during pregnancy, respectively

33. Effects of pregnancy on chronic urticaria: Results of the PREG‐CU UCARE study

34. Risk factors for systemic reactions in typical cold urticaria: results from the COLD-CE study

35. About the Results of the Destruction of the Molecules of Liquid Hydrocarbons in the Field of Acoustic Cavitation

36. Erratum: Benefits and harm of systemic steroids for short- A nd long-term use in rhinitis and rhinosinusitis: An EAACI position paper (Clinical and Translational Allergy (2020) 10 (1) DOI: 10.1186/s13601-019-0303-6)

37. Additional file 1 of Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

38. MOESM1 of Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

39. Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence

40. Definition, aims, and implementation of GA²LEN/HAEi Angioedema Centers of Reference and Excellence

41. Definition, aims, and implementation of GA(2)LEN/HAEi Angioedema Centers of Reference and Excellence

42. State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)

43. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper (vol 10, 1, 2020)

44. The role of mobile health technologies in allergy care: An EAACI position paper

45. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.

46. Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

47. The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria

48. The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology

50. Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence

Catalog

Books, media, physical & digital resources